Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of American Medical Systems Holdings, Inc. ("AMS" or the "Company") (NASDAQ: AMMD) related to the Company's agreement to be acquired by Endo Pharmaceuticals Holdings Inc. ("Endo"). The proposed transaction is valued at approximately $2.9 billion, including assumed debt.

Under the terms of the definitive agreement entered into by the parties, AMS shareholders will receive $30 in cash for each share they own of the Company's stock. The transaction is expected to close in third quarter 2011.

The investigation concerns whether the board of directors of AMS breached their fiduciary duties to AMS stockholders by failing to adequately shop the Company before agreeing to enter into the proposed transaction, and whether the Company has disclosed all material information to shareholders about the transaction. Specifically, the Company has seen substantial growth over the past year. For example, earnings per share grew 16.7% in fourth quarter 2011 compared to the same quarter in the previous year. Further, at least one analyst has set a target price of $29.00 per share, virtually nullifying any premium that AMS shareholders would receive under the transaction,

If you are a shareholder of AMS, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com